CIC-EC CIE Inserm, University Hospital of Nancy, France.
Am J Nephrol. 2011;33(1):76-83. doi: 10.1159/000322835. Epub 2010 Dec 17.
Some patients who reach end-stage renal disease refuse to start dialysis at the time suggested by their nephrologist and delay it. Whether this delay may affect health-related quality of life (HRQoL), clinical and biological parameters at dialysis onset, and then survival and hospitalization during dialysis is unknown.
We considered all adult patients who began dialysis in Lorraine (France) in 2005-2006 having previously been followed by a nephrologist. Clinical and biological characteristics at dialysis onset were collected from medical records, and nephrologists were interviewed about compliance with the recommended starting date. HRQoL was measured using the French version of the 'Kidney Disease Quality of Life' V36 questionnaire. Mortality and total duration of hospitalization during the first year of dialysis were recorded as part of the end-stage renal disease French registry. The effects of delaying dialysis on survival and on duration of hospitalization were determined using log-rank test and polychotomous logistic regression, respectively.
Of 541 patients, 88 (16.3%) declined to initiate dialysis at the time recommended by the nephrologist and delayed it. Compared with patients who were compliant with the advice, noncompliers had more comorbidities, poorer clinical and biological profiles at dialysis start, and a higher risk of beginning dialysis in emergency circumstances with greater decline in the 'burden of kidney disease' dimension of HRQoL. However, there were no differences in survival or duration of hospitalization during dialysis.
Despite a negative effect on clinical and biological parameters at initiation, delaying dialysis did not impact on survival during treatment.
一些终末期肾病患者拒绝在肾病医生建议的时间开始透析,并延迟透析。这种延迟是否会影响健康相关生活质量(HRQoL)、透析开始时的临床和生物学参数,以及随后透析期间的生存和住院情况尚不清楚。
我们考虑了 2005-2006 年在法国洛林地区开始透析的所有成年患者,这些患者之前都曾接受过肾病医生的随访。从病历中收集了透析开始时的临床和生物学特征,并且采访了肾病医生关于是否遵守推荐的起始日期的问题。使用法国版“肾脏病生活质量”V36 问卷测量 HRQoL。作为终末期肾脏疾病法国登记处的一部分,记录了透析第一年的死亡率和总住院时间。使用对数秩检验和多分类逻辑回归分别确定延迟透析对生存和住院时间的影响。
在 541 名患者中,有 88 名(16.3%)拒绝在肾病医生建议的时间开始透析并延迟了透析。与遵守建议的患者相比,不遵守者有更多的合并症,在开始透析时的临床和生物学特征更差,并且更有可能在紧急情况下开始透析,HRQoL 的“肾脏疾病负担”维度下降更大。然而,在透析期间的生存率或住院时间方面没有差异。
尽管延迟透析对开始时的临床和生物学参数有负面影响,但对治疗期间的生存没有影响。